- Home
- PBT vs VIR Comparison
PBT vs VIR Comparison
Compare PBT & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBT
- VIR
- Stock Information
- Founded
- PBT 1980
- VIR 2016
- Country
- PBT United States
- VIR United States
- Employees
- PBT N/A
- VIR N/A
- Industry
- PBT Oil & Gas Production
- VIR Biotechnology: Pharmaceutical Preparations
- Sector
- PBT Energy
- VIR Health Care
- Exchange
- PBT Nasdaq
- VIR Nasdaq
- Market Cap
- PBT 838.5M
- VIR 706.4M
- IPO Year
- PBT N/A
- VIR 2019
- Fundamental
- Price
- PBT $17.15
- VIR $5.63
- Analyst Decision
- PBT
- VIR Strong Buy
- Analyst Count
- PBT 0
- VIR 11
- Target Price
- PBT N/A
- VIR $25.73
- AVG Volume (30 Days)
- PBT 113.3K
- VIR 1.1M
- Earning Date
- PBT 01-01-0001
- VIR 10-30-2025
- Dividend Yield
- PBT 1.92%
- VIR N/A
- EPS Growth
- PBT N/A
- VIR N/A
- EPS
- PBT 0.35
- VIR N/A
- Revenue
- PBT $18,413,820.00
- VIR $19,000,000.00
- Revenue This Year
- PBT N/A
- VIR N/A
- Revenue Next Year
- PBT N/A
- VIR $15.25
- P/E Ratio
- PBT $49.95
- VIR N/A
- Revenue Growth
- PBT N/A
- VIR N/A
- 52 Week Low
- PBT $8.01
- VIR $4.16
- 52 Week High
- PBT $19.52
- VIR $14.45
- Technical
- Relative Strength Index (RSI)
- PBT 43.72
- VIR 59.22
- Support Level
- PBT $17.57
- VIR $5.36
- Resistance Level
- PBT $18.64
- VIR $6.00
- Average True Range (ATR)
- PBT 0.74
- VIR 0.28
- MACD
- PBT -0.23
- VIR 0.03
- Stochastic Oscillator
- PBT 0.84
- VIR 65.62
About PBT Permian Basin Royalty Trust
Permian Basin Royalty Trust is an express trust. The company's underlying properties include Waddell Ranch Properties in which the trust holds mineral interest as well as royalty interests in mature producing oil fields, such as Yates, Wasson, Sand Hills, East Texas, Kelly-Snyder, Panhandle Regular, N. Cowden, Todd, Keystone, Kermit, McElroy, Howard-Glasscock, Seminole and others across Texas. The company earns majority revenue in form of royalties received through its properties.
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.